{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:46:54Z","timestamp":1794246414656,"version":"4.9.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA241501"],"award-info":[{"award-number":["R01CA241501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL155198"],"award-info":[{"award-number":["R01HL155198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS094533"],"award-info":[{"award-number":["R01NS094533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS106108"],"award-info":[{"award-number":["R01NS106108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.molmed.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T08:14:37Z","timestamp":1701332077000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Reprogramming endothelial cells to empower cancer immunotherapy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-5940","authenticated-orcid":false,"given":"Abigail H.","family":"Cleveland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-0595","authenticated-orcid":false,"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.11.002_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents \u2013 overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2023.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"Ebos","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing function of tumor vessels: progress, opportunities, and challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0045","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2023.11.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature10525","article-title":"A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours","volume":"478","author":"Beck","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrc2791","article-title":"Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors","volume":"10","author":"Butler","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2010.01.001","article-title":"Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells","volume":"6","author":"Charles","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2012.12.021","article-title":"Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1","volume":"23","author":"Lu","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.trecan.2019.05.007","article-title":"Vascular detransformation for cancer therapy","volume":"5","author":"Fan","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccr.2014.02.005","article-title":"Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance","volume":"25","author":"Cao","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0095","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0100","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.169.7.3581","article-title":"B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis","volume":"169","author":"Mazanet","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","article-title":"Targeting the tumor vasculature to enhance T cell activity","volume":"33","author":"Lanitis","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41467-018-03050-0","article-title":"Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2alpha","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0120","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1158\/0008-5472.CAN-22-0076","article-title":"Endothelial RBPJ is essential for the education of tumor-associated macrophages","volume":"82","author":"Alsina-Sanchis","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00262-009-0747-y","article-title":"Tumors induce the formation of suppressor endothelial cells in vivo","volume":"59","author":"Mulligan","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.molmed.2023.11.002_bb0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.11.002_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0145","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cmet.2018.07.019","article-title":"Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation","volume":"28","author":"Bruning","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.11.002_bb0150","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1172\/JCI120912","article-title":"Endothelial pyruvate kinase M2 maintains vascular integrity","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.11.002_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42255-018-0011-x","article-title":"Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis","volume":"1","author":"Diebold","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2023.11.002_bb0160","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.15252\/embj.201796436","article-title":"Glutamine fuels proliferation but not migration of endothelial cells","volume":"36","author":"Kim","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2023.11.002_bb0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2019.08.011","article-title":"Hallmarks of endothelial cell metabolism in health and disease","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.11.002_bb0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2018.01.010","article-title":"A metabolic basis for endothelial-to-mesenchymal transition","volume":"69","author":"Xiong","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0175","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","article-title":"Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis","volume":"31","author":"Rohlenova","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.11.002_bb0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0185","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","article-title":"Vascular endothelial growth factor B controls endothelial fatty acid uptake","volume":"464","author":"Hagberg","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0190","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.15252\/embj.201695518","article-title":"Role of glutamine and interlinked asparagine metabolism in vessel formation","volume":"36","author":"Huang","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2023.11.002_bb0195","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2023.01.010","article-title":"PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.11.002_bb0200","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.apsb.2022.02.014","article-title":"Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.molmed.2023.11.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0210","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","article-title":"Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate","volume":"24","author":"Bunse","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0215","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature20165","article-title":"S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate","volume":"540","author":"Tyrakis","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0220","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-07-0942","article-title":"Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma","volume":"13","author":"Riesenberg","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0225","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0230","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0235","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.11.002_bb0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","article-title":"Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon","volume":"61","author":"Nguyen","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0250","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2018.01591","article-title":"Hypoxia-driven immunosuppressive metabolites in the tumor microenvironment: new approaches for combinational immunotherapy","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","article-title":"Targeting PAK4 to reprogram vascular microenvironment and improve CAR T immunotherapy for glioblastoma","volume":"2","author":"Ma","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm6388","article-title":"Tumors resurrect an embryonic vascular program to escape immunity","volume":"7","author":"Huijbers","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.matbio.2016.06.008","article-title":"Vascular laminins in physiology and pathology","volume":"57-58","author":"Di Russo","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.molmed.2023.11.002_bb0270","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0275","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.celrep.2012.10.021","article-title":"FGF regulates TGF-beta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2023.11.002_bb0280","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature12207","article-title":"EndMT contributes to the onset and progression of cerebral cavernous malformations","volume":"498","author":"Maddaluno","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature08761","article-title":"Blood stem cells emerge from aortic endothelium by a novel type of cell transition","volume":"464","author":"Kissa","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08738","article-title":"Haematopoietic stem cells derive directly from aortic endothelium during development","volume":"464","author":"Bertrand","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.11.002_bb0295","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0300","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1172\/JCI84876","article-title":"c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma","volume":"126","author":"Huang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.11.002_bb0305","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/0008-5472.CAN-20-0242","article-title":"YAP orchestrates heterotypic endothelial cell communication via HGF\/c-MET signaling in liver tumorigenesis","volume":"80","author":"Thomann","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0310","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/s41467-018-05982-z","article-title":"PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay7522","article-title":"Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma","volume":"12","author":"Huang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0320","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/s41467-018-07470-w","article-title":"Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0325","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/s41467-021-23832-3","article-title":"Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000432","article-title":"SOD3 induces a HIF-2alpha-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells","volume":"8","author":"Carmona-Rodriguez","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216034","article-title":"PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration","volume":"555","author":"Su","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2023.11.002_bb0340","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1172\/JCI125413","article-title":"STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade","volume":"129","author":"Yang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.11.002_bb0345","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0350","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/CIRCULATIONAHA.119.039767","article-title":"Endothelial forkhead box transcription factor P1 regulates pathological cardiac remodeling through transforming growth factor-beta1-endothelin-1 signal pathway","volume":"140","author":"Liu","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2023.11.002_bb0355","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s44161-022-00047-3","article-title":"Endothelial plasticity drives aberrant vascularization and impedes cardiac repair after myocardial infarction","volume":"1","author":"Huang","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0360","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","article-title":"Single-cell transcriptome atlas of murine endothelial cells","volume":"180","author":"Kalucka","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0365","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1158\/0008-5472.CAN-06-1609","article-title":"Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications","volume":"66","author":"Hellebrekers","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0370","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-023-37807-z","article-title":"Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors","volume":"14","author":"Kim","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0375","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms21072606","article-title":"The epigenetic profile of tumor endothelial cells. Effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression","volume":"21","author":"Ciesielski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.11.002_bb0380","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0167-5699(95)80023-9","article-title":"High endothelial venules (HEVs): specialized endothelium for lymphocyte migration","volume":"16","author":"Girard","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molmed.2023.11.002_bb0385","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.trecan.2020.10.001","article-title":"The dual role of high endothelial venules in cancer progression versus immunity","volume":"7","author":"Milutinovic","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.molmed.2023.11.002_bb0390","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0395","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2023.11.002_bb0400","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2023.11.002_bb0405","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.11.002_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2023.11.002_bb0415","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd.2015.2","article-title":"Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis","volume":"15","author":"Kreuger","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423002654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423002654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:29:29Z","timestamp":1761463769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491423002654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1471491423002654"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.11.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming endothelial cells to empower cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}